Allena Pharmaceuticals, Inc.
NASDAQ: ALNA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Louis Brenner
- Employees
- 12
- Headquarters
- Newton, United States
- IPO year
- 2017
- Website
- https://www.allenapharma.com
Loading ALNA…
Loading profile data…Frequently asked questions about ALNA
What does Allena Pharmaceuticals, Inc. (ALNA) do?
Allena Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and market introduction of orally administered enzyme therapies. Operating within the United States, the firm is dedicated to addressing debilitating metabolic and renal conditions, particularly those that are rare and severe. Its primary therapeuti...
Where does ALNA trade?
Allena Pharmaceuticals, Inc. (ALNA) trades on the NASDAQ Capital Market.
What sector is ALNA in?
Allena Pharmaceuticals, Inc. (ALNA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Allena Pharmaceuticals, Inc.?
Louis Brenner is the chief executive officer of Allena Pharmaceuticals, Inc. (ALNA).
Where is Allena Pharmaceuticals, Inc. headquartered?
Allena Pharmaceuticals, Inc. is headquartered in United States.
Does ALNA pay a dividend?
Allena Pharmaceuticals, Inc. (ALNA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALNA go public?
Allena Pharmaceuticals, Inc. (ALNA) completed its initial public offering in 2017.